Today is July 01, 2024. All times in Eastern Daylight Time.
Innate Pharma présente les résultats positifs de l’étude de Phase 2 TELLOMAK évaluant lacutamab dans le mycosis fongoïde
06/04/2024 - 01:00 AM
BUSINESS WIRE
Innate Pharma Presents Positive Results From TELLOMAK Phase 2 Study With Lacutamab in Mycosis Fungoides
06/04/2024 - 01:00 AM
BUSINESS WIRE
BenevolentAI to participate in Goldman Sachs 45th Annual Global Healthcare Conference
06/04/2024 - 01:00 AM
BUSINESS WIRE
1Password Strengthens EMEA Presence with Significant Business Growth, Key Customer Wins, and Region-Specific Product Capabilities
06/04/2024 - 01:00 AM
BUSINESS WIRE
e.l.f. Beauty Debuts “Show Your(s)e.l.f.” Self-Expression Documentary Series at Tribeca Festival
06/04/2024 - 12:01 AM
BUSINESS WIRE
Verbatim’s Next Chapter: New Logo Unveiled at Computex, Alongside Innovative Storage and Accessory Products
06/03/2024 - 11:18 PM
BUSINESS WIRE
Robbins LLP Urges DRCT Stockholders With Large Losses to Contact the Firm for Information About the Direct Digital Holdings, Inc. Class Action
06/03/2024 - 11:04 PM
BUSINESS WIRE
Hyve Solutions Integrates Latest Intel® Xeon® 6 Processor for Superior AI and Cloud Performance
06/03/2024 - 11:00 PM
BUSINESS WIRE
Intel Accelerates AI Everywhere at Computex 2024; Redefines Compute Power, Performance and Affordability with new Xeon 6, Gaudi Accelerators and Lunar Lake Architecture to Grow AI PC Leadership
06/03/2024 - 11:00 PM
BUSINESS WIRE
Enphase Energy, Inc. Investor Notice: Robbins LLP Reminds Stockholders of the ENPH Class Action Lawsuit
06/03/2024 - 10:57 PM
BUSINESS WIRE
1
...
1320
1321
1322
1323
1324
1325
1326
1327
1328
1329
1330
...
1414
« Previous
Next »